Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Caetano BC"" wg kryterium: Autor


Wyświetlanie 1-15 z 15
Tytuł:
Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-κB Non-Canonical Pathway and Mitochondrial Remodeling.
Autorzy:
Motta CS; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Torices S; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
da Rosa BG; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Marcos AC; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Alvarez-Rosa L; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.; Laboratório Compartilhado, Instituto de Ciências Biomédicas, UFRJ, Rio de Janeiro 05508-000, Brazil.
Siqueira M; Laboratório Compartilhado, Instituto de Ciências Biomédicas, UFRJ, Rio de Janeiro 05508-000, Brazil.
Moreno-Rodriguez T; Urology Department, University of California San Francisco, San Francisco, CA 94143, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA.
Matos ADR; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Caetano BC; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Martins JSCC; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Gladulich L; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Loiola E; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Bagshaw ORM; Faculty of Mathematics & Science, Brock University, St. Catharines, ON L2S 3A1, Canada.
Stuart JA; Faculty of Mathematics & Science, Brock University, St. Catharines, ON L2S 3A1, Canada.
Siqueira MM; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Stipursky J; Laboratório Compartilhado, Instituto de Ciências Biomédicas, UFRJ, Rio de Janeiro 05508-000, Brazil.
Toborek M; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Adesse D; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Mar 14; Vol. 15 (3). Date of Electronic Publication: 2023 Mar 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
NF-kappa B*/metabolism
COVID-19*/metabolism
Humans ; SARS-CoV-2/metabolism ; Endothelial Cells/metabolism ; Post-Acute COVID-19 Syndrome ; Brain ; Blood-Brain Barrier ; Mitochondria/metabolism
Czasopismo naukowe
Tytuł:
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020.
Autorzy:
Williams T; University of Edinburgh Edinburgh UK.
Jackson S; World Health Organization Geneva Switzerland.
Barr I; Peter Doherty Institute for Infection and Immunity WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Disease Reference Laboratory (VIDRL) Melbourne Victoria Australia.; Department of Microbiology and Immunology University of Melbourne Melbourne Victoria Australia.
Bi S; United Kingdom Health Security Agency (UKHSA) London UK.; United Kingdom National External Quality Assessment Service (UK NEQAS) for Microbiology London UK.
Bhiman J; Centre for Respiratory Diseases and Meningitis National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service Johannesburg South Africa.; School of Pathology, Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa.
Ellis J; United Kingdom Health Security Agency (UKHSA) London UK.
von Gottberg A; Centre for Respiratory Diseases and Meningitis National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service Johannesburg South Africa.; School of Pathology, Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa.
Lindstrom S; Respiratory Virus Branch, Division of Viral Diseases Centers for Disease Control and Prevention Atlanta Georgia USA.
Peret T; Division of Infectious Diseases, Department of Internal Medicine University of Texas Medical Branch Galveston Texas USA.; Institute for Human Infections and Immunity University of Texas Medical Branch Galveston Texas USA.
Rughooputh S; United Kingdom Health Security Agency (UKHSA) London UK.; United Kingdom National External Quality Assessment Service (UK NEQAS) for Microbiology London UK.
Viegas M; Virology Laboratory Ricardo Gutiérrez Children's Hospital Buenos Aires Argentina.; National Council for Scientific and Technological Research (CONICET) Buenos Aires Argentina.
Hirve S; World Health Organization Geneva Switzerland.
Zambon M; United Kingdom Health Security Agency (UKHSA) London UK.
Zhang W; World Health Organization Geneva Switzerland.
Dia N; Virology Department National Influenza Centre, Pasteur Institute of Dakar Dakar Senegal.
Razanazatovo N; National Influenza Laboratory Institut Pasteur de Madagascar Antananarivo Madagascar.
Al-Nabet ADMH; Qatar-HAMAD-NIC, Department of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar.
Abubakar A; Central Public Health Laboratory Ministry of Health Cairo Egypt.
Tivane A; Viral Isolation Laboratory, Department of Technological Platforms National Institute of Health/MISAU Marracuene Mozambique.
Barakat A; Eastern Mediterranean Regional Office World Health Organization Cairo Egypt.
Naguib A; Central Public Health Laboratory Ministry of Health Cairo Egypt.
Aziz A; Peter Doherty Institute for Infection and Immunity WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Disease Reference Laboratory (VIDRL) Melbourne Victoria Australia.
Vicari A; Pan American Health Organization Washington District of Columbia USA.
Moen A; World Health Organization Geneva Switzerland.
Govindakarnavar A; WHO Country Office Kathmandu Nepal.
Hall A; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA.
Darmaa B; Virology Laboratory National Center for Communicable Diseases Ulaanbaatar Mongolia.
Nathalie B; Influenza and Respiratory Viruses Section, National Microbiology Laboratory Public Health Agency of Canada Winnipeg Manitoba Canada.
Herring B; African Region Office World Health Organization Brazzaville Congo.
Caetano BC; Oswaldo Cruz Foundation Respiratory Virus Laboratory FIOCRUZ Rio de Janeiro Brazil.
Whittaker B; Respiratory Diseases Branch (RDB), Division of Bacterial Diseases (DBD) Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA.
Baumeister E; Respiratory Virosis Service, Virology Department INEI-ANLIS Dr. Carlos G Malbrán Buenos Aires Argentina.
Nakouné E; Epidemiological Surveillance Pasteur Institute of Bangui Bangui Central African Republic.
Guthrie E; International Reagent Resources (IRR), Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA.
Inbanathan F; South-East Asia Region Office World Health Organization New Delhi India.
Nair H; Medical School The University of Edinburgh Edinburgh UK.
Campbell H; Usher Institute of Population Health Research and Informatics University of Edinburgh Edinburgh UK.
Kadjo HA; Department of Epidemic Viruses Pasteur Institute of Ivory Coast Abidjan Côte d'Ivoire.
Oumzil H; Virology Department, Manager of National Influenza Center National Institute of Hygiene, Ministry of Health Rabat Morocco.
Heraud JM; National Influenza Laboratory Institut Pasteur de Madagascar Antananarivo Madagascar.
Mott JA; US CDC Thailand sub-regional office Nonthaburi Thailand.
Namulondo J; Uganda Virus Research Institute Entebbe Uganda.
Leite J; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA.
Nahapetyan K; Western Pacific Region Office World Health Organization Manila Philippines.
Al Ariqi L; Eastern Mediterranean Region Office World Health Organization Cairo Egypt.
Gazo MHI; Central Public Health Laboratory Ministry of Health Cairo Egypt.
Chadha M; National Institute of Virology Indian Council of Medical Research Pune India.
Pisareva M; Laboratory of Molecular Virology Smorodintsev Research Institute of Influenza St. Petersburg Russian Federation.
Venter M; Center for Viral Zoonosis, Department of Medical Virology University of Pretoria Pretoria South Africa.
Siqueira MM; Laboratorio de Virus Respiratorios, IOC/FIOCRUZ Rio de Janeiro Brazil.
Lumandas M; Department of Health Research Institute for Tropical Medicine Muntinlupa Philippines.
Niang M; Virology Department National Influenza Centre, Pasteur Institute of Dakar Dakar Senegal.
Albuaini M; National Influenza Centre, Research Laboratory Rafic Hariri University Hospital Beirut Lebanon.
Salman M; Central of Public Health Laboratory National Institute of Health Islamabad Pakistan.
Oberste S; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA.
Srikantiah P; Bill and Melinda Gates Foundation Seattle Washington USA.
Tang P; Sidra Medicine Doha Qatar.
Couto P; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA.
Smith P; MRC International Statistics and Epidemiology Group London School of Hygiene and Tropical Medicine London UK.
Coyle PV; Qatar-HAMAD-NIC, Department of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar.
Dussart P; National Influenza Laboratory Institut Pasteur de Madagascar Antananarivo Madagascar.
Nguyen PN; Western Pacific Region Office World Health Organization Manila Philippines.
Okada PA; Department of Medical Sciences Respiratory virus section, Thai NIC, National Institute of Health Nonthaburi Thailand.
Wijesinghe PR; South-East Asia Region Office World Health Organization New Delhi India.
Samuel R; South-East Asia Region Office World Health Organization New Delhi India.
Brown R; South-East Asia Region Office World Health Organization New Delhi India.
Pebody R; Regional Office for Europe World Health Organization Copenhagen Denmark.
Fasce R; Sub-department of Viral Diseases Institute of Public Health of Chile Santiago Chile.
Jha R; National Public Health Laboratory, Department of Health Services Ministry of Health and Population Kathmandu Nepal.
Lindstrom S; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA.
Gerber S; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA.
Potdar V; National Institute of Virology Indian Council of Medical Research Pune India.
Dong X; Peter Doherty Institute for Infection and Immunity WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Disease Reference Laboratory (VIDRL) Melbourne Victoria Australia.
Deng YM; Peter Doherty Institute for Infection and Immunity WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Disease Reference Laboratory (VIDRL) Melbourne Victoria Australia.
Pokaż więcej
Corporate Authors:
WHO RSV Surveillance Group
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jan 18; Vol. 17 (1), pp. e13073. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Respiratory Syncytial Virus, Human*/genetics
Viruses*
United States ; Humans ; Laboratories ; World Health Organization ; Australia
Czasopismo naukowe
Tytuł:
Sera of patients infected by earlier lineages of SARS-CoV-2 are capable to neutralize later emerged variants of concern.
Autorzy:
Pauvolid-Corrêa A; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.; Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843, USA.; Departamento de Veterinária, Universidade Federal de Viçosa (UFV), Viçosa, MG 36570-900, Brazil.
Caetano BC; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Machado AB; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Ferreira MA; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Valente N; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Neves TK; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Geraldo K; Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, RJ 21040-900, Brazil.
Motta F; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Dos Santos VGV; Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, RJ 21040-900, Brazil.
Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, RJ 21040-900, Brazil.
Siqueira MM; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Resende PC; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Pokaż więcej
Źródło:
Biology methods & protocols [Biol Methods Protoc] 2022 Aug 22; Vol. 7 (1), pp. bpac021. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil.
Autorzy:
Capão A; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Aguiar-Oliveira ML; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Caetano BC; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Neves TK; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Resende PC; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Almeida WAF; Secretariat of Surveillance in Health (SVS), Ministry of Health (MoH), Brasília-Federal District, Rio de Janeiro 70723-040, Brazil.
Miranda MD; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Martins-Filho OAS; Grupo Integrado de Pesquisas em Biomarcadores, René Rachou Institute, FIOCRUZ, Belo Horizonte 30190-002, Brazil.
Brown D; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
Siqueira MM; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Garcia CC; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Jul 30; Vol. 14 (8). Date of Electronic Publication: 2022 Jul 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza A Virus, H1N1 Subtype*/genetics
Influenza Vaccines*
Influenza, Human*
Adult ; Antibodies, Viral ; Brazil/epidemiology ; Hemagglutination Inhibition Tests ; Humans ; Seasons ; Vaccines, Inactivated
Czasopismo naukowe
Tytuł:
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.
Autorzy:
Melgaço JG; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Azamor T; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Silva AMV; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Linhares JHR; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Dos Santos TP; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Mendes YS; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
de Lima SMB; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Fernandes CB; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
da Silva J; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
de Souza AF; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Tubarão LN; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Brito E Cunha D; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Pereira TBS; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Menezes CEL; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Miranda MD; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Matos AR; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Caetano BC; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Martins JSCC; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Calvo TL; Laboratório de Hanseníase, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Rodrigues NF; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.; Centro de Desenvolvimento Tecnológico em Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Sacramento CQ; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.; Centro de Desenvolvimento Tecnológico em Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Siqueira MM; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Moraes MO; Laboratório de Hanseníase, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Missailidis S; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Neves PCC; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Ano Bom APD; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Pokaż więcej
Źródło:
Cells [Cells] 2021 Aug 26; Vol. 10 (9). Date of Electronic Publication: 2021 Aug 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunity, Cellular*
Models, Biological*
COVID-19/*immunology
COVID-19/*virology
SARS-CoV-2/*physiology
Adult ; Alveolar Epithelial Cells/virology ; COVID-19/blood ; COVID-19/genetics ; Cytokines/genetics ; Cytokines/metabolism ; Female ; Gene Expression Regulation ; Humans ; Immunologic Memory/immunology ; Killer Cells, Natural/immunology ; Leukocytes, Mononuclear/virology ; Male ; Middle Aged ; Phenotype ; T-Lymphocytes/immunology ; Virus Replication/physiology ; Young Adult
Czasopismo naukowe
Tytuł:
Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis.
Autorzy:
Meyer VMC; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Siqueira MM; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Costa PFBM; Pulmonology Department, National Institute of Women, Children and Adolescents Health Fernandes Figueira - IFF/FIOCRUZ, Rio de Janeiro, Brazil.; Pediatrics Department, Federal University of the State of Rio de Janeiro - UNIRIO, Rio de Janeiro, Brazil.
Caetano BC; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Oliveira Lopes JC; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Folescu TW; Pulmonology Department, National Institute of Women, Children and Adolescents Health Fernandes Figueira - IFF/FIOCRUZ, Rio de Janeiro, Brazil.
Motta FDC; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Oct 28; Vol. 15 (10), pp. e0240452. Date of Electronic Publication: 2020 Oct 28 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cystic Fibrosis/*virology
Respiratory Syncytial Virus, Human/*isolation & purification
Respiratory Tract Infections/*virology
Rhinovirus/*isolation & purification
Adolescent ; Brazil/epidemiology ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Nasopharynx/virology ; Prevalence ; Prospective Studies ; Respiratory Tract Infections/epidemiology
Czasopismo naukowe
Tytuł:
The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi.
Autorzy:
Ersching J; Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil.
Vasconcelos JR; Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil.; Departamento de Biociências, Universidade Federal de São Paulo, Santos, São Paulo, Brazil.
Ferreira CP; Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil.
Caetano BC; Departments of Medicine and Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Machado AV; Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil.
Bruna-Romero O; Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil.
Baron MA; Instituto do Coração (InCor), Faculdade de Medicina - Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Ferreira LR; Instituto do Coração (InCor), Faculdade de Medicina - Universidade de São Paulo, São Paulo, São Paulo, Brazil.; Universidade Santo Amaro, São Paulo, São Paulo, Brazil.
Cunha-Neto E; Instituto do Coração (InCor), Faculdade de Medicina - Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Rock KL; Departments of Medicine and Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Gazzinelli RT; Departments of Medicine and Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.; Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil.; Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Rodrigues MM; Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2016 Apr 29; Vol. 12 (4), pp. e1005593. Date of Electronic Publication: 2016 Apr 29 (Print Publication: 2016).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD8-Positive T-Lymphocytes/*immunology
Chagas Disease/*immunology
Proteasome Endopeptidase Complex/*immunology
Protozoan Vaccines/*immunology
Adolescent ; Adult ; Animals ; Enzyme-Linked Immunosorbent Assay ; Female ; Flow Cytometry ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Middle Aged ; Real-Time Polymerase Chain Reaction ; Trypanosoma cruzi ; Young Adult
Czasopismo naukowe
Tytuł:
Serum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection.
Autorzy:
Micic D; Division of Gastroenterology, Hepatology and Nutrition, University of Chicago , IL, USA.
Rao K; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Division of Infectious Diseases, University of Michigan Health System , Ann Arbor, MI, USA.
Trindade BC; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Department of Microbiology and Immunology, University of Michigan Health System , Ann Arbor, MI, USA.
Walk ST; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Division of Infectious Diseases, University of Michigan Health System , Ann Arbor, MI, USA.
Chenoweth E; University of Michigan Medical School , Ann Arbor, MI, USA.
Jain R; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Division of Infectious Diseases, University of Michigan Health System , Ann Arbor, MI, USA.
Trivedi I; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA.
Santhosh K; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Division of Infectious Diseases, University of Michigan Health System , Ann Arbor, MI, USA.
Young VB
Aronoff DM
Pokaż więcej
Źródło:
Infectious disease reports [Infect Dis Rep] 2015 Sep 29; Vol. 7 (3), pp. 5979. Date of Electronic Publication: 2015 Sep 29 (Print Publication: 2015).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
Autorzy:
Starling AL; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .; b Fundação Centro De Hematologia E Hemoterapia De Minas Gerais - HEMOMINAS , Santa Efigênia, Minas Gerais , Brazil .; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil .
Coelho-Dos-Reis JG; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .
Peruhype-Magalhães V; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .
Pascoal-Xavier MA; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil .; d Department of Anatomic Pathology , Medicine School, Federal University of Minas Gerais , Belo Horizonte, Minas Gerais , Brazil .
Gonçalves DU; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil .
Béla SR; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .
Lambertucci JR; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil .
Labanca L; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil .
Souza Pereira SR; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil .
Teixeira-Carvalho A; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .
Ribas JG; e Hospital Sarah Kubitschek , Belo Horizonte, Minas Gerais , Brazil , and.
Trindade BC; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .; f Laboratório De Inflamação E Imunologia Das Parasitoses , Faculdade De Ciências Farmacêuticas De Ribeirão Preto, Universidade De São Paulo , Ribeirão Preto, São Paulo , Brazil.
Faccioli LH; f Laboratório De Inflamação E Imunologia Das Parasitoses , Faculdade De Ciências Farmacêuticas De Ribeirão Preto, Universidade De São Paulo , Ribeirão Preto, São Paulo , Brazil.
Carneiro-Proietti AB; b Fundação Centro De Hematologia E Hemoterapia De Minas Gerais - HEMOMINAS , Santa Efigênia, Minas Gerais , Brazil .
Martins-Filho OA; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .
Pokaż więcej
Źródło:
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2015; Vol. 20 (6-7), pp. 502-12. Date of Electronic Publication: 2015 Oct 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers/*blood
HTLV-I Infections/*blood
Inflammation Mediators/*blood
Paraparesis, Tropical Spastic/*blood
Adult ; Aged ; Blotting, Western ; Chemokine CXCL10/blood ; Chemokine CXCL10/immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; HTLV-I Infections/immunology ; HTLV-I Infections/virology ; Host-Pathogen Interactions/immunology ; Human T-lymphotropic virus 1/immunology ; Human T-lymphotropic virus 1/physiology ; Humans ; Inflammation Mediators/immunology ; Interferon-gamma/blood ; Interferon-gamma/immunology ; Interleukin-10/blood ; Interleukin-10/immunology ; Interleukin-4/blood ; Interleukin-4/immunology ; Interleukin-6/blood ; Interleukin-6/immunology ; Leukotriene B4/blood ; Leukotriene B4/immunology ; Male ; Middle Aged ; Paraparesis, Tropical Spastic/immunology ; Paraparesis, Tropical Spastic/virology ; Receptors, Leukotriene/blood ; Receptors, Leukotriene/immunology ; Signal Transduction/immunology ; Tumor Necrosis Factor-alpha/blood ; Tumor Necrosis Factor-alpha/immunology ; Young Adult
Czasopismo naukowe
Tytuł:
Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders.
Autorzy:
Coelho-dos-Reis JG; Laboratório de Biomarcadores de Diagnóstico e Monitoração, Instituto René Rachou, FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil.
Passos L
Duarte MC
Araújo MG
Campi-Azevedo AC
Teixeira-Carvalho A
Peruhype-Magalhães V
Trindade BC
Dos Santos Dias R
Martins ML
Carneiro-Proietti AB
Guedes AC
Gonçalves DU
Martins-Filho OA
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2013 Jul 25; Vol. 7 (7), pp. e2328. Date of Electronic Publication: 2013 Jul 25 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Autoimmune Diseases/*complications
HTLV-I Infections/*complications
HTLV-I Infections/*immunology
Human T-lymphotropic virus 1/*immunology
Skin Diseases/*complications
Adult ; Carrier State/epidemiology ; Carrier State/immunology ; Female ; HTLV-I Infections/epidemiology ; Human T-lymphotropic virus 1/isolation & purification ; Humans ; Killer Cells, Natural/immunology ; Lymphocyte Subsets/immunology ; Macrophages/immunology ; Male ; Middle Aged ; Viral Load
Czasopismo naukowe
Tytuł:
Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1.
Autorzy:
Mendes ÉA; Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Fonseca FG
Casério BM
Colina JP
Gazzinelli RT
Caetano BC
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 May 15; Vol. 8 (5), pp. e63201. Date of Electronic Publication: 2013 May 15 (Print Publication: 2013).
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Vectors*
Adenoviridae/*genetics
Antigens, Protozoan/*genetics
Protozoan Proteins/*genetics
Toxoplasma/*immunology
Vaccines, Synthetic/*immunology
Animals ; Antibodies, Protozoan/blood ; Cytokines/metabolism ; Female ; Immunity, Cellular ; Mice ; Mice, Inbred C57BL ; Spleen/cytology ; Spleen/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Transgenes ; Vaccines, Synthetic/administration & dosage
Czasopismo naukowe
Tytuł:
Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infection.
Autorzy:
Pereira PA; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
Trindade BC
Secatto A
Nicolete R
Peres-Buzalaf C
Ramos SG
Sadikot R
Bitencourt Cda S
Faccioli LH
Pokaż więcej
Źródło:
Mediators of inflammation [Mediators Inflamm] 2013; Vol. 2013, pp. 950981. Date of Electronic Publication: 2013 Apr 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cyclooxygenase 2 Inhibitors/*therapeutic use
Histoplasma/*pathogenicity
Histoplasmosis/*drug therapy
Histoplasmosis/*metabolism
Pyrazoles/*therapeutic use
Sulfonamides/*therapeutic use
Animals ; Celecoxib ; Histoplasma/drug effects ; Interferon-gamma/metabolism ; Leukotriene B4/metabolism ; Macrophages, Alveolar/drug effects ; Macrophages, Alveolar/metabolism ; Mice ; Mice, Inbred C57BL ; Nitric Oxide/metabolism
Czasopismo naukowe
Tytuł:
Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory disease.
Autorzy:
Trindade BC; Laboratório de Inflamação e Imunologia das Parasitoses, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Sao Paulo, Brazil.
Sorgi CA
Nicolete LD
Malta TM
Pinto MT
Takayanagui OM
Covas DT
Martins Filho OA
Kashima S
Faccioli LH
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (12), pp. e51873. Date of Electronic Publication: 2012 Dec 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1/*immunology
Leukotrienes/*metabolism
Paraparesis, Tropical Spastic/*virology
Adult ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Cells, Cultured ; Chemokines/genetics ; Chemokines/metabolism ; Female ; Human T-lymphotropic virus 1/pathogenicity ; Humans ; Leukocytes, Mononuclear/immunology ; Leukocytes, Mononuclear/metabolism ; Leukocytes, Mononuclear/virology ; Leukotrienes/genetics ; Male ; Middle Aged ; Paraparesis, Tropical Spastic/immunology ; Paraparesis, Tropical Spastic/metabolism ; Proviruses/genetics ; RNA, Messenger/genetics ; Real-Time Polymerase Chain Reaction ; Receptors, Leukotriene/genetics ; Receptors, Leukotriene/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Viral Load
Czasopismo naukowe
    Wyświetlanie 1-15 z 15

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies